S100A14 and nasopharyngeal carcinoma: Meng et al. have found that IRAK4 is extremely upregulated in nasopharyngeal carcinoma cells, and S100A14 could inhibit NF-κB pathway to impede the progression of the cancer via targeting IRAK4 [23].